Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists
It is remarkable to see formerly obese individuals undergo a miraculous slimming over several months on once weekly injections of glucagon-like peptide-1 receptor agonists.
These drugs originally designed for type 2 diabetes, are associated with consistent weight loss, however, more muscle is lost than with conventional dieting.
Khan et al summarized several clinical trials where patients were followed after stopping the GLP-1 RA. Sadly, about 2/3 of the pounds gone came back on average as most patients returned to their usual eating habits and lack of exercise.
This paper should be a reminder that any weight loss drug is a means to an end and that diet and exercise must fundamentally change during the period of weight loss to prevent regain.
It has been my experience that longer durations on the drug help solidify losses in weight (>9 months).
Final diets free of sugar, starch, and saturated fats are best for keeping weight off. Additionally strength training and building muscle mass instead of losing it helps with the transition back to life off the weekly injections.
See more here Substack
Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.
Frank S.
| #
All good advice. But using instead a natural producer of the GLP-1 effect like the probiotic akkermansia is a much safer and cheaper alternative than Ozempic.
https://principia-scientific.com/the-biggest-drug-fraud-in-history
Reply